Sarepta Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: SRPT
Share price (3/27/26): $19.97
Market cap (3/27/26): $2.097 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 10-Q/A 99 pages Warrant to Purchase Common Stock of Myonexus Therapeutics, Inc

from 10-Q 99 pages Warrant to Purchase Common Stock of Myonexus Therapeutics, Inc

from 8-K12B 6 pages Agreement and Plan of Merger of Sarepta Therapeutics, Inc., a Delaware Corporation, and Sarepta Therapeutics, Inc., an Oregon Corporation

from 8-K 71 pages Agreement and Plan of Merger Dated March 12, 2008 by and Among Avi Biopharma, Inc., Eb Acquisition Corp., Ercole Biotech, Inc. and the Stockholder Representative (Without Exhibits)